Skip to main content
OpenTrials

Clinical trial condition

Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Explore clinical trials studying Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) trial results

Recruiting

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

NCT06589440

Conditions
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
Locations
  • Atlantic Health Morristown, New Jersey, United States
  • Texas Oncology- Austin Austin, Texas, United States
  • Texas Oncology- Sammons- DFW Dallas, Texas, United States
  • The University of Texas M.D. Anderson Cancer Center GI Medical Oncology Dept Houston, Texas, United States
View Trial Details